Skip to content

The Effect of Tablet Size on Cognitive Performance Caffeine

The Effect of Tablet Size on Cognitive Performance: A Randomized Control Trial Using Caffeine

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03694886
Acronym
CaC
Enrollment
120
Registered
2018-10-03
Start date
2018-10-31
Completion date
2019-03-01
Last updated
2019-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placebo Effect

Brief summary

This study aims to assess if tablet size, due to placebo effect, alters participants' performance on cognitive tests after consuming caffeine. Participants will be randomly assigned to one of four groups: 1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule.

Detailed description

Background: A capsule's physical design (e.g. shape, size, and color) affects individuals' perception of drug efficacy; that is, how well a drug is likely to work. The goal of this study is to assess the effects tablet size may have on participant's performance on cognitive testing since research has found differences between preparation methods. Method: 120 participants will be randomly assigned to one of four groups: 1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule. Participants will consume the designated placebo tablet with water (caffeinated or non-caffeinated); then, participants will provide weekly caffeine intake and complete the neutral portion of Velten's Mood Induction Procedure until 30 minutes have passed to allow for caffeine activation. Participants will complete the Stroop test, Trial Making Tests A and B, and the Rey Auditory Verbal Learning Test. Previous literature, as far as the author knows, relied on evaluating drug efficacy based on appearance alone. This study aims to assess if tablet size, due to placebo effect, alters participants' performance on cognitive tests after consuming caffeine.

Interventions

DRUGCaffeine Anhydrous with small sucrose pill

caffeine anhydrous that has been weighed out to 90 mg per dose presented with a 1 mm sucrose pillule

OTHERPlacebo - large sucrose pill

sucrose pillules of 5 mm diameter will be given to all participants in the large pill groups

DRUGCaffeine Anhydrous with large sucrose pill

caffeine anhydrous that has been weighed out to 90 mg per dose presented with a 5 mm sucrose pillule

OTHERPlacebo - small sucrose pill

sucrose pillules of 1 mm diameter will be given to all participants in the small pill groups

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Masking description

Participants will not be made aware if they have or have not received caffeine to not bias results.

Intervention model description

Participants will be randomly assigned to one of four groups: 1\) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule.

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Fluent in written and spoken English * Ability to see color * No uncontrolled high blood pressure * No allergies to caffeine or sucrose * No history of heart disease * No untreated anxiety or depression * Non-pregnant * No caffeine consumed the day of participation

Exclusion criteria

* Not fluent in written and/or spoken English * Uncontrolled high blood pressure * Color-blindness * Allergies to caffeine and/or sucrose * History of heart disease * Untreated anxiety or depression * Pregnant * Consumed caffeine on the day of participation

Design outcomes

Primary

MeasureTime frameDescription
Stroop Color testWithin 90 minutes of receiving informed consent. Actual task time: approximately 1.5 minutesMeasures processing speed. 100-item, time-trial task where participants read the color of printed items on the task paper as quickly as possible for 45 seconds. Scores are measured in the number of correct responses within the allotted time.
Stroop Word testWithin 90 minutes of receiving informed consent. Actual task time: approximately 1.5 minutesMeasures processing speed. 100-item, time-trial task where participants read color names printed on the task paper as quickly as possible for 45 seconds. Scores are measured in the number of correct responses within the allotted time.
Trail Making task AWithin 90 minutes of receiving informed consent. Actual task time: approximately 2 minutesMeasures processing speed. 25 item, time-trial task where participants must connect numbers in order as quickly as possible. Scores are measured by the amount of time (in seconds) for participants to complete the task.

Secondary

MeasureTime frameDescription
Stroop Color-and-Word testWithin 90 minutes of receiving informed consent. Actual task time: approximately 2 minutesMeasures processing speed. 100-item, time-trial task where participants must read the color of the ink instead of color names printed on the task paper as quickly as possible for 45 seconds. Scores are measured in the number of correct responses within the allotted time.
Trail Making task BWithin 90 minutes of receiving informed consent. Actual task time: approximately 3 minutesMeasures processing speed. 25 item, time-trial task where participants must connect numbers and letters in order (e.g. 1-A-2-B, etc.) as quickly as possible. Scores are measured by the amount of time (in seconds) for participants to complete the task.
Rey Auditory Verbal Learning testWithin 90 minutes of receiving informed consent. Actual task time: approximately 40 minutesMeasures memory. 30-item, 2 section task where participants are read 15 words and asked to recall as many words as possible in the first section. A second set of 15 words is then introduced and participants recall those. The second section consists of revisiting the original set of words and recalling as many of those. Scores are measured by the total words remembered in section one, and another score for the total intrusions from the second list into the recall of section two.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026